Royalty Pharma plc
NASDAQ:RPRX
25.85 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 477.01 | 1,710.751 | 1,541.048 | 1,009 | 283.682 | 1,924.211 | 1,381.571 | 1,674.219 | 1,720.871 |
Short Term Investments
| 18.3 | 717.04 | 1,262.223 | 983 | 509.532 | 461.821 | 0 | 0 | 0 |
Cash and Short Term Investments
| 495.31 | 2,427.791 | 2,803.271 | 1,992 | 793.214 | 2,386.032 | 1,381.571 | 1,674.219 | 1,720.871 |
Net Receivables
| 775.085 | 727.916 | 682.66 | 626.359 | 491.326 | 660.448 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 657.136 | 0 | 19.196 | 0 | 0 | 0 |
Other Current Assets
| 3.798 | 90.52 | 6.631 | 8.596 | 0.092 | -14.497 | 1,566.149 | 1,329.854 | 1,323.046 |
Total Current Assets
| 1,274.193 | 2,554.908 | 2,878.211 | 2,696.898 | 832.072 | 2,608.554 | 2,947.72 | 3,004.073 | 3,043.917 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 1.778 | 14.5 | 5.67 | 28.666 | 51.724 | 75.648 | 0 | 0 | 6,949.488 |
Goodwill and Intangible Assets
| 1.778 | 14.5 | 5.67 | 28.666 | 51.724 | 75.648 | 0 | 0 | 6,949.488 |
Long Term Investments
| 1,012.481 | 14,228.929 | 14,627.839 | 13,266.125 | 11,478.149 | 8,666.834 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 14,093.399 | 15.129 | 4.145 | 28.597 | 87.95 | 19.111 | 0 | 0 | 822.277 |
Total Non-Current Assets
| 15,107.658 | 14,258.558 | 14,637.654 | 13,323.388 | 11,617.823 | 8,761.593 | 8,425.812 | 7,477.926 | 7,771.765 |
Total Assets
| 16,381.851 | 16,813.466 | 17,515.865 | 21,097.036 | 12,449.895 | 11,370.147 | 11,373.532 | 10,481.999 | 10,815.682 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 15.165 | 7.906 | 5.62 | 10.775 | 11.177 | 4.477 | 0 | 0 | 0 |
Short Term Debt
| 0 | 997.512 | 0 | 0 | 281.984 | 281.436 | 280.928 | 172.684 | 184.383 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 31.041 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 146.212 | 161.365 | 165.63 | 297.112 | 40.256 | 294.259 | 102.485 | 124.634 | 130.007 |
Total Current Liabilities
| 161.377 | 1,166.783 | 171.25 | 307.887 | 333.417 | 580.172 | 383.413 | 297.318 | 314.39 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 6,135.285 | 6,118.81 | 7,096.07 | 5,816.584 | 5,956.138 | 6,237.896 | 6,520.855 | 5,724.69 | 5,804.19 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.9 | 2.5 | 0 | 0 | 18.902 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 6,136.185 | 6,121.31 | 7,096.07 | 5,816.584 | 5,975.04 | 6,237.896 | 6,520.855 | 5,724.69 | 5,804.19 |
Total Liabilities
| 6,297.562 | 7,288.093 | 7,267.32 | 6,124 | 6,308.457 | 6,818.068 | 6,904.268 | 6,022.008 | 6,118.58 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.045 | 0.107 | 0.106 | 0.102 | 3,282.516 | 3,282.516 | 0 | 0 | 0 |
Retained Earnings
| 2,517.583 | 1,964.689 | 2,255.179 | 1,920.635 | 2,825.212 | 1,215.953 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0.063 | 0.063 | 16.491 | 34.395 | 2.093 | -10.255 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 4,008.806 | 3,663.354 | 3,504.818 | 2,863.647 | -4.266 | 0 | 4,460.546 | 4,445.62 | 4,676.908 |
Total Shareholders Equity
| 6,526.497 | 5,628.15 | 5,776.594 | 9,896 | 6,105.555 | 4,488.214 | 4,460.546 | 4,445.62 | 4,676.908 |
Total Equity
| 10,084.289 | 9,525.373 | 10,248.545 | 14,973.036 | 6,141.438 | 4,552.079 | 4,460.546 | 4,445.62 | 4,676.908 |
Total Liabilities & Shareholders Equity
| 16,381.851 | 16,813.466 | 17,515.865 | 21,097.036 | 12,449.895 | 11,370.147 | 11,364.814 | 10,467.628 | 10,795.488 |